Zobrazeno 1 - 10
of 850
pro vyhledávání: '"combinational therapy"'
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-37 (2024)
Abstract PD-1/PD-L1 blockade therapies have displayed extraordinary clinical efficacy for melanoma, renal, bladder and lung cancer; however, only a minority of colorectal cancer (CRC) patients benefit from these treatments. The efficacy of PD-1/PD-L1
Externí odkaz:
https://doaj.org/article/75b7d016520743e0bde80f8c51b15e62
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide. Recent advances in immunotherapies, targeted therapies, and combination treatments have significantly improved outcomes for many patients with HCC. This review
Externí odkaz:
https://doaj.org/article/a6b278c12e5e41cda0deff756acccc24
Autor:
Sandeep Sisodiya, Vishakha Kasherwal, Jyoti Rani, Neetu Mishra, Sandeep Kumar, Asiya Khan, Mehreen Aftab, Shagufta, Payal Singh, Ekta Gupta, Pranay Tanwar, Showket Hussain
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundBreast cancer has the highest mortality rate among all cancers affecting females worldwide. Several new effective therapeutic strategies are being developed to minimize the number of breast cancer-related deaths and improve the quality of l
Externí odkaz:
https://doaj.org/article/9f03349f52804f10a2cd847d2a5da40c
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
The increasing threat of antibiotic resistance and shrinking treatment options for infections have pushed mankind into a difficult position. The looming threat of the return of the pre-antibiotic era has caused a sense of urgency to protect and conse
Externí odkaz:
https://doaj.org/article/f2c3659472f54cafa268a65b746c7583
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Liver cancer is a major global health concern, ranking among the top causes of cancer-related deaths worldwide. Despite advances in medical research, the prognosis for liver cancer remains poor, largely due to the inherent limitations of current ther
Externí odkaz:
https://doaj.org/article/0473331ddc5f43fbb465e4f35f2ee05d
Autor:
Zhaokui Zeng, Jingjing Tian, Wenjie Xu, Hailu Liu, Daxiong Xiang, Dehua Liao, Junyong Wu, Chuanpin Chen
Publikováno v:
Materials & Design, Vol 245, Iss , Pp 113270- (2024)
The treatment of breast cancer (BC) remains a significant challenge, exemplified by the limitations of chemotherapy due to its high side effects. Light-responsive drug delivery systems (DDS) offer a promising approach to spatially and temporally rele
Externí odkaz:
https://doaj.org/article/22eff99deee64d10898fa86fbadfb0e2
Publikováno v:
Nanomaterials, Vol 14, Iss 21, p 1760 (2024)
Psoriasis and breast cancer are two examples of diseases where associated inflammatory pathways within the body’s immune system are implicated. Psoriasis is a complex, chronic and incurable inflammatory skin disorder that is primarily recognized by
Externí odkaz:
https://doaj.org/article/e40d8fce7b1141eb951f7648147ec142
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2152 (2024)
Background: Although immunotherapy has shown potential in cancer treatment, current immunotherapeutics for bladder cancer are limited by a low response rate. Therefore, it is necessary to investigate other suitable immunotherapeutic targets and strat
Externí odkaz:
https://doaj.org/article/8db267586fa24262b4b3f9c641417b78
Autor:
Kwang-sun Kim
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Graphical Abstract
Externí odkaz:
https://doaj.org/article/b6e06befa402491086093485aab8336f
Publikováno v:
Smart Molecules, Vol 2, Iss 1, Pp n/a-n/a (2024)
Abstract Glutathione (GSH)‐activated prodrugs are promising for overcoming the limitations of conventional anti‐tumor drugs. However, current GSH‐responsive disulfide groups exhibit unregulated reactivity, making it impossible to precisely cont
Externí odkaz:
https://doaj.org/article/05a498a10f0f4fe3bb3364121671e627